After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Axonics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $68.36 and fluctuated between $68.50 as its day high and $68.17 as its day low. The current market capitalization of Axonics Inc is $3.46B. A total of 1.21 million shares were traded on the day, compared to an average of 985.14K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AXNX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 24 BUYs and 38 SELLs from insiders. Insiders purchased 282,177 shares during that period but sold 182,165.
In the most recent transaction, Noblett Karen sold 15,999 shares of AXNX for 69.00 per share on Jan 08. After the transaction, the Chief Medical Officer now owns 18,216 company shares. In a previous transaction on Dec 28, Noblett Karen sold 7,051 shares at 63.28 per share. AXNX shares that Chief Medical Officer owns now total 34,215.
Among the insiders who sold shares, Noblett Karen disposed of 949 shares on Dec 26 at a per-share price of $63.00. This resulted in the Chief Medical Officer holding 41,266 shares of AXNX after the transaction. In another insider transaction, Dearen Danny L. sold 7,675 shares at $56.87 per share on Sep 29. Company shares held by the President & CFO now total 23,777.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AXNX in the last 3 months, the mean price target is $71.46 with high estimates of $75.00 and low estimates of $65.00. In terms of 52-week highs and lows, AXNX has a high of $69.68 and a low of $47.59.
As of this writing, AXNX has an earnings estimate of $0.06 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.12 per share and a lower estimate of -$0.02. The company reported an EPS of -$0.15 in the last quarter, which was -36.40% lower than expectations of -$0.11.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AXNX’s latest balance sheet shows that the firm has $220.88M in Cash & Short Term Investments as of fiscal 2021. There were $10.42M in debt and $26.87M in liabilities at the time. Its Book Value Per Share was $12.05, while its Total Shareholder’s Equity was $482.44M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXNX is Buy with a score of 3.69.
